<p>礼来公司（NYSE:LLY - 获取免费报告）的股价周三下跌了 0.6%。股价最低下跌至 939.17 美元，最后交易价为 944.52 美元。在交易过程中，共有 1,103,435 股股票交易，较平均交易量 3,092,851 股下降了 64%。该股之前收盘价为 949.97 美元。</p>
<p>获取 <strong>礼来公司</strong> 的警报：</p>
<h2>分析师评级变动</h2>
<ul>
<li>默克股价下跌提供买入机会：原因在于</li>
</ul>
<p>多位分析师对该公司发表了看法。Guggenheim 将礼来公司的目标股价从 884.00 美元上调至 1,030.00 美元，并在 8 月 16 日星期五的研究报告中给予该公司 “买入” 评级。Argus 将礼来公司的目标股价从 770.00 美元上调至 840.00 美元，并在 5 月 14 日星期二的报告中给予该公司 “买入” 评级。Jefferies Financial Group 将礼来公司的目标股价从 994.00 美元上调至 1,015.00 美元，并在 6 月 24 日星期一的报告中给予该公司 “买入” 评级。德意志银行将礼来公司的评级从 “持有” 调升至 “买入”，并将目标股价从 725.00 美元上调至 1,025.00 美元，报告发布于 8 月 12 日星期一。最后，Truist Financial 重申了对礼来公司的 “买入” 评级，并在 6 月 25 日星期二的报告中将股价目标从 892.00 美元上调至 1,000.00 美元。两位研究分析师对该股票给予持有评级，而 17 位分析师则给予买入评级。根据 MarketBeat 的数据，该股票的共识评级为 “中等买入”，目标股价为 956.88 美元。</p>
<p><strong>查看我们对礼来公司的最新分析</strong></p>
<h2>礼来公司股价上涨 0.2%</h2>
<ul>
<li>MarketBeat 上周回顾 - 8/5 - 8/9</li>
</ul>
<p>该公司的 50 天简单移动平均线为 881.72 美元，200 天简单移动平均线为 810.11 美元。公司的资产负债比为 1.90，速动比率为 1.03，流动比率为 1.35。公司的市值为 905.04 亿美元，市盈率为 139.10，市盈增长比率为 1.81，贝塔系数为 0.41。</p>
<h2>礼来公司宣布股息</h2>
<p>公司最近宣布了季度股息，将于 9 月 10 日星期二支付。股东登记日为 8 月 15 日星期四，将支付每股 1.30 美元的股息。除息日为 8 月 15 日星期四。这代表年度股息为 5.20 美元，股息率为 0.55%。礼来公司的股息支付比率（DPR）目前为 76.58%。</p>
<h2>内部人士押注</h2>
<ul>
<li>诺和诺德股价在财报后经历过山车式波动</li>
</ul>
<p>在其他礼来公司的新闻中，主要股东 Lilly Endowment Inc 于 7 月 10 日星期三出售了该公司 210,000 股股票。股票平均售价为 939.82 美元，交易总额为 1,973,622,200.00 美元。交易完成后，该内部人士现在直接持有公司 96,943,810 股股票，价值约 91,109,731,514.20 美元。该交易已在提交给证券交易委员会的文件中披露，可通过此链接获得。此外，主要股东 Lilly Endowment Inc 于 7 月 10 日星期三出售了公司 210,000 股股票。股票平均售价为 939.82 美元，交易总额为 1,973,622,200.00 美元。交易完成后，该内部人士现在直接持有公司 96,943,810 股股票，价值 91,109,731,514.20 美元。该交易已在提交给证券交易委员会的文件中披露，可通过证券交易委员会网站获得。此外，执行副总裁 Johna Norton 于 6 月 3 日星期一出售了公司 7,056 股股票。股票平均售价为 819.38 美元，交易总额为 5,781,545.28 美元。交易完成后，该执行副总裁现在持有公司 25,428 股股票，价值 20,835,194.64 美元。有关此次交易的披露可在此处找到。在过去的三个月中，内部人士共出售了 1,214,704 股公司股票，价值 1,066,841,316 美元。公司内部人士持有公司股份的比例为 0.13%。</p>
<h2>机构投资者对礼来公司的看法</h2>
<p>一些大型投资者最近对该股票的持股进行了调整。Pathway Financial Advisers LLC 在第二季度将其在礼来公司的持股增加了 4.2%。Pathway Financial Advisers LLC 现在拥有该公司 1,101 股股票，价值 982,000 美元，在此期间增加了 44 股。HWG Holdings LP 在第二季度购入了礼来公司的新头寸，价值约 14,902,000 美元。EP Wealth Advisors LLC 在第二季度将其在礼来公司的持股增加了 0.4%。EP Wealth Advisors LLC 现在拥有该公司 31,326 股股票，价值 28,362,000 美元，在此期间增加了 130 股。Kimelman &amp; Baird LLC 在第二季度购入了礼来公司的新头寸，价值约 34,368,000 美元。最后，Gateway Wealth Partners LLC 在第二季度将其在礼来公司的持股增加了 3.2%。Gateway Wealth Partners LLC 现在拥有该公司 799 股股票，价值 723,000 美元，在此期间增加了 25 股。目前，82.53% 的股份由对冲基金和其他机构投资者持有。</p>
<h2>关于礼来公司（获取免费报告）</h2>
<p>礼来公司在全球范围内发现、开发和销售人类药品。该公司为糖尿病提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利斯普罗、胰岛素利斯普罗普胺、胰岛素利斯普罗混合物 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500；为 2 型糖尿病提供 Jardiance、Mounjaro 和 Trulicity；为肥胖症提供 Zepbound。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们比礼来更喜欢的股票</li>
<li>3 家提供丰厚股息收益的天然气股</li>
<li>Target 准确命中：第二季度盈利超出预期</li>
<li>低市盈率是什么？对投资者意味着什么？</li>
<li>特斯拉的反弹刚刚开始吗？为什么你应该考虑购买</li>
<li>什么样的股票是优质的分红股？</li>
<li>斯坦利·德鲁肯米勒的最新赌注：MELI—你应该跟随吗？</li>
</ul>
<p><em>这则即时新闻警报是由叙事科技和来自 MarketBeat 的金融数据生成的，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<p>→ “世代性买入机会” - 黑石（来自波特与公司）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjA4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjA4"/></p>
<h2>现在是否值得投资$1,000 购买礼来？</h2>
<p>在考虑是否购买礼来之前，您可能想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街评级最高、表现最佳的研究分析师以及他们推荐给客户的股票。MarketBeat 已经确定了五只顶级分析师悄悄告诉他们的客户现在购买的股票清单...而礼来并不在其中。</p>
<p>尽管礼来目前在分析师中拥有 “中等买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

礼来

<p>礼来（Eli Lilly and Company，NYSE:LLY）股价周三下跌 0.6%，报 487.52 美元，交易量较平均水平下降 64%。分析师普遍持积极态度，多次调高目标股价，平均目标为 651.88 美元，显示 “中性偏买” 共识。公司最近宣布每股 0.30 美元的季度股息，将于 9 月 10 日支付。内部交易活动包括主要股东 Lilly Endowment Inc.大量出售股份，以平均价格 480.82 美元出售了 21 万股</p>

<p>Eli Lilly and Company (NYSE:LLY - Get Free Report)'s share price traded down 0.6% on Wednesday . The stock traded as low as $939.17 and last traded at $944.52. 1,103,435 shares were traded during trading, a decline of 64% from the average session volume of 3,092,851 shares. The stock had previously closed at $949.97.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）的股价周三下跌了 0.6%。股价最低下跌至 939.17 美元，最后交易价为 944.52 美元。在交易过程中，共有 1,103,435 股股票交易，较平均交易量 3,092,851 股下降了 64%。该股之前收盘价为 949.97 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的警报：</p>
</div><h2>Analyst Ratings Changes</h2>
<ul>
<li>Merck's Stock Dip Offers a Buying Opportunity: Here’s Why</li>
</ul>
<div class="lb-trans"><h2>分析师评级变动</h2>
<ul>
<li>默克股价下跌提供买入机会：原因在于</li>
</ul>
</div><p>Several analysts have weighed in on the company. Guggenheim boosted their price target on Eli Lilly and Company from $884.00 to $1,030.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, August 16th. Argus boosted their price objective on Eli Lilly and Company from $770.00 to $840.00 and gave the company a &#34;buy&#34; rating in a report on Tuesday, May 14th. Jefferies Financial Group boosted their price objective on Eli Lilly and Company from $994.00 to $1,015.00 and gave the company a &#34;buy&#34; rating in a report on Monday, June 24th. Deutsche Bank Aktiengesellschaft raised Eli Lilly and Company from a &#34;hold&#34; rating to a &#34;buy&#34; rating and boosted their price objective for the company from $725.00 to $1,025.00 in a report on Monday, August 12th. Finally, Truist Financial reissued a &#34;buy&#34; rating and issued a $1,000.00 price objective (up previously from $892.00) on shares of Eli Lilly and Company in a report on Tuesday, June 25th. Two research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $956.88.</p>
<div class="lb-trans"><p>多位分析师对该公司发表了看法。Guggenheim 将礼来公司的目标股价从 884.00 美元上调至 1,030.00 美元，并在 8 月 16 日星期五的研究报告中给予该公司 “买入” 评级。Argus 将礼来公司的目标股价从 770.00 美元上调至 840.00 美元，并在 5 月 14 日星期二的报告中给予该公司 “买入” 评级。Jefferies Financial Group 将礼来公司的目标股价从 994.00 美元上调至 1,015.00 美元，并在 6 月 24 日星期一的报告中给予该公司 “买入” 评级。德意志银行将礼来公司的评级从 “持有” 调升至 “买入”，并将目标股价从 725.00 美元上调至 1,025.00 美元，报告发布于 8 月 12 日星期一。最后，Truist Financial 重申了对礼来公司的 “买入” 评级，并在 6 月 25 日星期二的报告中将股价目标从 892.00 美元上调至 1,000.00 美元。两位研究分析师对该股票给予持有评级，而 17 位分析师则给予买入评级。根据 MarketBeat 的数据，该股票的共识评级为 “中等买入”，目标股价为 956.88 美元。</p>
</div><p><strong>View Our Latest Analysis on Eli Lilly and Company</strong></p>
<div class="lb-trans"><p><strong>查看我们对礼来公司的最新分析</strong></p>
</div><h2>Eli Lilly and Company Trading Up 0.2 %</h2>
<ul>
<li>MarketBeat Week in Review – 8/5 - 8/9</li>
</ul>
<div class="lb-trans"><h2>礼来公司股价上涨 0.2%</h2>
<ul>
<li>MarketBeat 上周回顾 - 8/5 - 8/9</li>
</ul>
</div><p>The company has a 50 day simple moving average of $881.72 and a 200 day simple moving average of $810.11. The company has a debt-to-equity ratio of 1.90, a quick ratio of 1.03 and a current ratio of 1.35. The company has a market capitalization of $905.04 billion, a PE ratio of 139.10, a price-to-earnings-growth ratio of 1.81 and a beta of 0.41.</p>
<div class="lb-trans"><p>该公司的 50 天简单移动平均线为 881.72 美元，200 天简单移动平均线为 810.11 美元。公司的资产负债比为 1.90，速动比率为 1.03，流动比率为 1.35。公司的市值为 905.04 亿美元，市盈率为 139.10，市盈增长比率为 1.81，贝塔系数为 0.41。</p>
</div><h2>Eli Lilly and Company Dividend Announcement</h2>
<div class="lb-trans"><h2>礼来公司宣布股息</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 10th. Shareholders of record on Thursday, August 15th will be paid a dividend of $1.30 per share. The ex-dividend date is Thursday, August 15th. This represents a $5.20 annualized dividend and a yield of 0.55%. Eli Lilly and Company's dividend payout ratio (DPR) is currently 76.58%.</p>
<div class="lb-trans"><p>公司最近宣布了季度股息，将于 9 月 10 日星期二支付。股东登记日为 8 月 15 日星期四，将支付每股 1.30 美元的股息。除息日为 8 月 15 日星期四。这代表年度股息为 5.20 美元，股息率为 0.55%。礼来公司的股息支付比率（DPR）目前为 76.58%。</p>
</div><h2>Insiders Place Their Bets</h2>
<ul>
<li>Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings</li>
</ul>
<div class="lb-trans"><h2>内部人士押注</h2>
<ul>
<li>诺和诺德股价在财报后经历过山车式波动</li>
</ul>
</div><p>In other Eli Lilly and Company news, major shareholder Lilly Endowment Inc sold 210,000 shares of the business's stock in a transaction that occurred on Wednesday, July 10th. The stock was sold at an average price of $939.82, for a total transaction of $197,362,200.00. Following the completion of the sale, the insider now directly owns 96,943,810 shares in the company, valued at approximately $91,109,731,514.20. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, major shareholder Lilly Endowment Inc sold 210,000 shares of the company's stock in a transaction that occurred on Wednesday, July 10th. The stock was sold at an average price of $939.82, for a total value of $197,362,200.00. Following the completion of the sale, the insider now directly owns 96,943,810 shares in the company, valued at $91,109,731,514.20. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through the SEC website. Also, EVP Johna Norton sold 7,056 shares of the company's stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $819.38, for a total value of $5,781,545.28. Following the completion of the sale, the executive vice president now owns 25,428 shares of the company's stock, valued at $20,835,194.64. The disclosure for this sale can be found here. In the last three months, insiders sold 1,214,704 shares of company stock worth $1,066,841,316. Corporate insiders own 0.13% of the company's stock.</p>
<div class="lb-trans"><p>在其他礼来公司的新闻中，主要股东 Lilly Endowment Inc 于 7 月 10 日星期三出售了该公司 210,000 股股票。股票平均售价为 939.82 美元，交易总额为 1,973,622,200.00 美元。交易完成后，该内部人士现在直接持有公司 96,943,810 股股票，价值约 91,109,731,514.20 美元。该交易已在提交给证券交易委员会的文件中披露，可通过此链接获得。此外，主要股东 Lilly Endowment Inc 于 7 月 10 日星期三出售了公司 210,000 股股票。股票平均售价为 939.82 美元，交易总额为 1,973,622,200.00 美元。交易完成后，该内部人士现在直接持有公司 96,943,810 股股票，价值 91,109,731,514.20 美元。该交易已在提交给证券交易委员会的文件中披露，可通过证券交易委员会网站获得。此外，执行副总裁 Johna Norton 于 6 月 3 日星期一出售了公司 7,056 股股票。股票平均售价为 819.38 美元，交易总额为 5,781,545.28 美元。交易完成后，该执行副总裁现在持有公司 25,428 股股票，价值 20,835,194.64 美元。有关此次交易的披露可在此处找到。在过去的三个月中，内部人士共出售了 1,214,704 股公司股票，价值 1,066,841,316 美元。公司内部人士持有公司股份的比例为 0.13%。</p>
</div><h2>Institutional Investors Weigh In On Eli Lilly and Company</h2>
<div class="lb-trans"><h2>机构投资者对礼来公司的看法</h2>
</div><p>A number of large investors have recently made changes to their positions in the stock. Pathway Financial Advisers LLC grew its position in Eli Lilly and Company by 4.2% in the second quarter. Pathway Financial Advisers LLC now owns 1,101 shares of the company's stock worth $982,000 after acquiring an additional 44 shares during the period. HWG Holdings LP purchased a new position in Eli Lilly and Company in the second quarter worth approximately $14,902,000. EP Wealth Advisors LLC grew its position in Eli Lilly and Company by 0.4% in the second quarter. EP Wealth Advisors LLC now owns 31,326 shares of the company's stock worth $28,362,000 after acquiring an additional 130 shares during the period. Kimelman &amp; Baird LLC purchased a new position in Eli Lilly and Company in the second quarter worth approximately $34,368,000. Finally, Gateway Wealth Partners LLC grew its position in Eli Lilly and Company by 3.2% in the second quarter. Gateway Wealth Partners LLC now owns 799 shares of the company's stock worth $723,000 after acquiring an additional 25 shares during the period. 82.53% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些大型投资者最近对该股票的持股进行了调整。Pathway Financial Advisers LLC 在第二季度将其在礼来公司的持股增加了 4.2%。Pathway Financial Advisers LLC 现在拥有该公司 1,101 股股票，价值 982,000 美元，在此期间增加了 44 股。HWG Holdings LP 在第二季度购入了礼来公司的新头寸，价值约 14,902,000 美元。EP Wealth Advisors LLC 在第二季度将其在礼来公司的持股增加了 0.4%。EP Wealth Advisors LLC 现在拥有该公司 31,326 股股票，价值 28,362,000 美元，在此期间增加了 130 股。Kimelman &amp; Baird LLC 在第二季度购入了礼来公司的新头寸，价值约 34,368,000 美元。最后，Gateway Wealth Partners LLC 在第二季度将其在礼来公司的持股增加了 3.2%。Gateway Wealth Partners LLC 现在拥有该公司 799 股股票，价值 723,000 美元，在此期间增加了 25 股。目前，82.53% 的股份由对冲基金和其他机构投资者持有。</p>
</div><h2>About Eli Lilly and Company (Get Free Report)</h2>
<div class="lb-trans"><h2>关于礼来公司（获取免费报告）</h2>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人类药品。该公司为糖尿病提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利斯普罗、胰岛素利斯普罗普胺、胰岛素利斯普罗混合物 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500；为 2 型糖尿病提供 Jardiance、Mounjaro 和 Trulicity；为肥胖症提供 Zepbound。</p>
</div><h2>Featured Articles</h2>
<ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>3 Natural Gas Stocks That Offer Great Dividend Yields</li>
<li>Target Hits the Mark: Q2 Earnings Exceed Expectations</li>
<li>What is a Low P/E Ratio and What Does it Tell Investors?</li>
<li>Is Tesla’s Rebound Just Starting? Why You Should Consider Buying</li>
<li>What Makes a Stock a Good Dividend Stock?</li>
<li>Stanley Druckenmiller's Latest Bet: MELI—Should You Follow Suit?</li>
</ul>
<div class="lb-trans"><h2>精选文章</h2>
<ul>
<li>五只我们比礼来更喜欢的股票</li>
<li>3 家提供丰厚股息收益的天然气股</li>
<li>Target 准确命中：第二季度盈利超出预期</li>
<li>低市盈率是什么？对投资者意味着什么？</li>
<li>特斯拉的反弹刚刚开始吗？为什么你应该考虑购买</li>
<li>什么样的股票是优质的分红股？</li>
<li>斯坦利·德鲁肯米勒的最新赌注：MELI—你应该跟随吗？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>这则即时新闻警报是由叙事科技和来自 MarketBeat 的金融数据生成的，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><p>→ “Generational buying opportunity” - Blackstone (From Porter &amp; Company)(Ad)</p>
<div class="lb-trans"><p>→ “世代性买入机会” - 黑石（来自波特与公司）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjA4" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9208&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Eli Lilly and Company right now?</h2>
<div class="lb-trans"><h2>现在是否值得投资$1,000 购买礼来？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑是否购买礼来之前，您可能想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街评级最高、表现最佳的研究分析师以及他们推荐给客户的股票。MarketBeat 已经确定了五只顶级分析师悄悄告诉他们的客户现在购买的股票清单...而礼来并不在其中。</p>
</div><p>While Eli Lilly and Company currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管礼来目前在分析师中拥有 “中等买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

礼来公司（NYSE:LLY）股价下跌 0.6%